Clinical Trial Update: A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Shengxuening Tablet in chemotherapy-related anemia associated with hematologic tumors; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer-related Anemia
• Hematological Malignancy

Drugs mentioned

• Shengxuening Tablet

Snippet

Sponsor: Zhongnan Hospital | Conditions: Hematological Malignancy, Cancer-Related Anemia | Phase 3 | Status: UNKNOWN